Symbol="PBYI"
AssetType="Common Stock"
Name="Puma Biotechnology Inc"
Description="Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California."
CIK="1401667"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10880 WILSHIRE BLVD., SUITE 2150, LOS ANGELES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="178421000"
EBITDA="38422000"
PERatio="34.73"
PEGRatio="0.03"
BookValue="0.648"
DividendPerShare="0"
DividendYield="0"
EPS="0.11"
RevenuePerShareTTM="4.981"
ProfitMargin="-0.0106"
OperatingMarginTTM="0.125"
ReturnOnAssetsTTM="0.0909"
ReturnOnEquityTTM="-0.0973"
RevenueTTM="230120000"
GrossProfitTTM="172938000"
DilutedEPSTTM="0.11"
QuarterlyEarningsGrowthYOY="-0.781"
QuarterlyRevenueGrowthYOY="-0.083"
AnalystTargetPrice="4.75"
TrailingPE="34.73"
ForwardPE="11.29"
PriceToSalesRatioTTM="1.045"
PriceToBookRatio="9.06"
EVToRevenue="1.092"
EVToEBITDA="7.87"
Beta="1.051"
num_52WeekHigh="5.16"
num_52WeekLow="2.08"
num_50DayMovingAverage="3.438"
num_200DayMovingAverage="3.502"
SharesOutstanding="46707000"
DividendDate="None"
ExDividendDate="None"
symbol="PBYI"
open="3.38"
high="4.08"
low="3.38"
price="3.82"
volume="599095.00"
latest_trading_day="2023-08-04"
previous_close="3.52"
change="0.30"
change_percent="8.5227%"
aroon_positive_momentum_days="46"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="249622"
Change_recent_avg="0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_negative_thumbnail_id_2="1136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="626"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
